Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram
The Korean Journal of Internal Medicine
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials - Annals of Oncology
Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma – Karyopharm Therapeutics
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
Tool for Capturing DLBCL Prognosis: The Revised International Prognostic Index (R-IPI)
Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies | Translational Medicine Communications | Full Text
Novel prognostic scoring system for diffuse large B-cell lymphoma
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma | Haematologica
Diffuse large B cell lymphoma: Outlook, stages, treatment
Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Diffuse Large B-cell Lymphoma Prognosis Calculator
Molecular profiling of large B-Cell lymphomas : A retrospective observational pilot study
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials | Semantic Scholar
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurately Predict Survival Risk And Improve Treatment Decisions
